Why the study?
Is higher Monocyte-to-HDL Cholesterol Ratio (MHR) associated with the presence of slow coronary flow (SCF)?
Is higher Monocyte-to-HDL Cholesterol Ratio (MHR) associated with the presence of slow coronary flow (SCF)?
Higher Monocyte-to-HDL Cholesterol Ratio is associated with slow coronary flow and systemic inflammation, suggesting its potential utility as a biomarker.
Answers are grounded in this paper and cite their sources.
MHR may aid inflammation assessment in SCF; leaves open prospective validation before clinical adoption.
Higher MHR which indicates an enhanced inflammation and oxidative stress was significantly and independently associated with the presence of SCF. Besides, MHR was positively correlated with serum hsCRP level as a conventional marker for systemic inflammation.
No takes yet. Share an insight, caveat, or question.
Canpolat et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: